About: What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
Creator	George, Jacob Eslam, Mohammed Abenavoli, Ludovico Romero-Gómez, M Teschke, Rolf Yoshida, Eric Carrion, Andres Em, Yoshida Keaveny, Andrew Méndez-Sánchez, Méndez-Sánchez, Nahum Qi, Xingshun Romero-Gómez, Manuel Valencia-Rodríguez, Alejandro Xie, Weifen
source	Medline; PMC; WHO
abstract	covid:08397cfd7c03fc339e42c1d4bb82449c54c7b111#abstract
has issue date	2020-04-11(xsd:dateTime)
bibo:doi	10.14218/jcth.2020.00024
bibo:pmid	32309152
has license	cc-by-nc
sha1sum (hex)	08397cfd7c03fc339e42c1d4bb82449c54c7b111
schema:url	https://doi.org/10.14218/jcth.2020.00024
resource representing a document's title	What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
has PubMed Central identifier	PMC7163687
has PubMed identifier	32309152
schema:publication	J Clin Transl Hepatol
resource representing a document's body	covid:08397cfd7c03fc339e42c1d4bb82449c54c7b111#body_text
is schema:about of	named entity 'gamma-glutamyl transferase' named entity 'levels of care' named entity 'Spain' named entity 'multiple regression analysis' named entity 'virus' named entity 'outpatient setting' named entity 'COVID' named entity 'Systemic inflammation' named entity 'critically ill patients' named entity 'COVID' named entity 'hypoalbuminemia' named entity 'receptor' named entity 'case report' named entity 'liver' named entity 'Asian' named entity 'immunosuppressive therapy' named entity 'systemic inflammation' named entity 'DRB1' named entity 'liver' named entity 'NCP' named entity 'critical illness' named entity 'strictly speaking' named entity 'epithelial cells' named entity 'Chinese Medical Association' named entity 'liver' named entity 'Pandemic' named entity 'COVID-19' named entity 'SARS-CoV' named entity 'bile duct' named entity 'epidemic' named entity 'morbidity' named entity 'China' named entity 'synergistically' named entity 'prognosis' named entity 'COVID-19' named entity 'infection' named entity 'liver damage' named entity 'ACE2' named entity 'COVID' named entity 'viral replication' named entity 'gastroenterologists' named entity 'alkaline phosphatase' named entity 'Western Europe' named entity 'Italy' named entity 'lung' named entity 'infection' named entity 'AST' named entity 'lopinavir' named entity 'liver' named entity 'hepatic' named entity 'viral hepatitis' named entity 'cell differentiation' named entity 'COVID' named entity 'chronic liver disease' named entity 'telemedicine' named entity 'bile duct injury' named entity 'proinflammatory cytokines' named entity 'liver' named entity 'COVID-19' named entity 'North America' named entity 'COVID-19' named entity 'alcoholic liver disease' named entity 'morbidity' named entity 'betacoronavirus' named entity 'lactate dehydrogenase' named entity 'COVID-19' named entity 'coronavirus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software